111 related articles for article (PubMed ID: 23259994)
41. Inducible nuclear factor-kappaB activation contributes to chemotherapy resistance in gastric cancer.
Camp ER; Li J; Minnich DJ; Brank A; Moldawer LL; MacKay SL; Hochwald SN
J Am Coll Surg; 2004 Aug; 199(2):249-58. PubMed ID: 15275881
[TBL] [Abstract][Full Text] [Related]
42. [Dihydropyrimidine dehydrogenase and thymidylate synthase activities in colonic cancer tissue and sensitivity to 5-fluorouracil].
Araki S; Isomoto H; Matsumoto A; Kaihara J; Yasunaga M; Hayashi K; Yatsugi H; Yamauchi K
Nihon Geka Gakkai Zasshi; 1999 Dec; 100(12):822. PubMed ID: 10766580
[No Abstract] [Full Text] [Related]
43. Annexin A1 is involved in resistance to 5-FU in colon cancer cells.
Onozawa H; Saito M; Saito K; Kanke Y; Watanabe Y; Hayase S; Sakamoto W; Ishigame T; Momma T; Ohki S; Takenoshita S
Oncol Rep; 2017 Jan; 37(1):235-240. PubMed ID: 27840982
[TBL] [Abstract][Full Text] [Related]
44. Isolation and characterization of calcium sensing receptor null cells: a highly malignant and drug resistant phenotype of colon cancer.
Singh N; Liu G; Chakrabarty S
Int J Cancer; 2013 May; 132(9):1996-2005. PubMed ID: 23055106
[TBL] [Abstract][Full Text] [Related]
45. Chemoresistance of CD133(+) colon cancer may be related with increased survivin expression.
Lee MR; Ji SY; Mia-Jan K; Cho MY
Biochem Biophys Res Commun; 2015 Jul; 463(3):229-34. PubMed ID: 26002465
[TBL] [Abstract][Full Text] [Related]
46. The effects of 5-fluorouracil on the proteome of colon cancer cells.
Marin-Vicente C; Lyutvinskiy Y; Romans Fuertes P; Zubarev RA; Visa N
J Proteome Res; 2013 Apr; 12(4):1969-79. PubMed ID: 23477467
[TBL] [Abstract][Full Text] [Related]
47. Dual role of autophagy in colon cancer cell survival.
Yang SY; Winslet MC
Ann Surg Oncol; 2011 Dec; 18 Suppl 3():S239. PubMed ID: 21603870
[No Abstract] [Full Text] [Related]
48. Regrowth of 5-fluorouracil-treated human colon cancer cells is prevented by the combination of interferon gamma, indomethacin, and phenylbutyrate.
Huang Y; Horvath CM; Waxman S
Cancer Res; 2000 Jun; 60(12):3200-6. PubMed ID: 10866311
[TBL] [Abstract][Full Text] [Related]
49. Reversing resistance of multidrug-resistant hepatic carcinoma cells with parthenolide.
Liu D; Liu Y; Liu M; Ran L; Li Y
Future Oncol; 2013 Apr; 9(4):595-604. PubMed ID: 23560381
[TBL] [Abstract][Full Text] [Related]
50. Involvement of RhoGDI2 in the resistance of colon cancer cells to 5-fluorouracil.
Zheng Z; Li J; He X; Chen X; Yu B; Ji J; Zhang J; Wang T; Gu Q; Zhu Z; Liu B
Hepatogastroenterology; 2010; 57(102-103):1106-12. PubMed ID: 21410040
[TBL] [Abstract][Full Text] [Related]
51. [Molecular biological analysis of 5-fluorouracil sensitivity in colorectal neoplasm].
Kubota T; Yoshinare K; Kabeshima Y; Watanabe M; Kitajima M
Nihon Rinsho; 2003 Sep; 61 Suppl 7():321-4. PubMed ID: 14574903
[No Abstract] [Full Text] [Related]
52. Thiacremonone augments chemotherapeutic agent-induced growth inhibition in human colon cancer cells through inactivation of nuclear factor-{kappa}B.
Ban JO; Lee HS; Jeong HS; Song S; Hwang BY; Moon DC; Yoon DY; Han SB; Hong JT
Mol Cancer Res; 2009 Jun; 7(6):870-9. PubMed ID: 19531569
[TBL] [Abstract][Full Text] [Related]
53. 5-Fluorouracil induces apoptosis through the suppression of NF-kappaB activity in human salivary gland cancer cells.
Aota K; Azuma M; Yamashita T; Tamatani T; Motegi K; Ishimaru N; Hayashi Y; Sato M
Biochem Biophys Res Commun; 2000 Jul; 273(3):1168-74. PubMed ID: 10891390
[TBL] [Abstract][Full Text] [Related]
54. Endoplasmic reticulum stress induces 5-fluorouracil resistance in human colon cancer cells.
Kim JK; Kang KA; Piao MJ; Ryu YS; Han X; Fernando PM; Oh MC; Park JE; Shilnikova K; Boo SJ; Na SY; Jeong YJ; Jeong SU; Hyun JW
Environ Toxicol Pharmacol; 2016 Jun; 44():128-33. PubMed ID: 27163731
[TBL] [Abstract][Full Text] [Related]
55. The β6-integrin-ERK/MAP kinase pathway contributes to chemo resistance in colon cancer.
Liu S; Wang J; Niu W; Liu E; Wang J; Peng C; Lin P; Wang B; Khan AQ; Gao H; Liang B; Shahbaz M; Niu J
Cancer Lett; 2013 Jan; 328(2):325-34. PubMed ID: 23073477
[TBL] [Abstract][Full Text] [Related]
56. Effectiveness of adjuvant fluorouracil in elderly colon cancer patients: the internal and external validity of nonrandomized research design.
Apolone G; Cavuto S; Torri V; la Vecchia C
J Clin Oncol; 2003 May; 21(9):1892; author reply 1893. PubMed ID: 12721271
[No Abstract] [Full Text] [Related]
57. Primary cultures of human colon cancer as a model to study cancer stem cells.
Koshkin S; Danilova A; Raskin G; Petrov N; Bajenova O; O'Brien SJ; Tomilin A; Tolkunova E
Tumour Biol; 2016 Sep; 37(9):12833-12842. PubMed ID: 27449036
[TBL] [Abstract][Full Text] [Related]
58. Effect of an omega-3 fatty acid containing lipid emulsion alone and in combination with 5-fluorouracil (5-FU) on growth of the colon cancer cell line Caco-2.
Jordan A; Stein J
Eur J Nutr; 2003 Dec; 42(6):324-31. PubMed ID: 14673605
[TBL] [Abstract][Full Text] [Related]
59. Epidermal growth factor receptor vIII enhances tumorigenicity and resistance to 5-fluorouracil in human hepatocellular carcinoma.
Wang H; Jiang H; Zhou M; Xu Z; Liu S; Shi B; Yao X; Yao M; Gu J; Li Z
Cancer Lett; 2009 Jun; 279(1):30-8. PubMed ID: 19217205
[TBL] [Abstract][Full Text] [Related]
60. Geraniol, a component of plant essential oils, sensitizes human colonic cancer cells to 5-Fluorouracil treatment.
Carnesecchi S; Langley K; Exinger F; Gosse F; Raul F
J Pharmacol Exp Ther; 2002 May; 301(2):625-30. PubMed ID: 11961066
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
